Experimental use of photodynamic therapy in high grade gliomas: a review focused on 5-aminolevulinic acid.

Photodynamic therapy (PDT) consists of a laser light exposure of tumor cells photosensitized by general or local administration of a pharmacological agent. Nowadays, PDT is a clinically established modality for treatment of many cancers. 5-Aminolevulinic acid (ALA) induced protoporphyrin IX (PpIX) has proven its rational in fluoro-guided resection of malignant gliomas due to a selective tumor uptake and minimal skin sensitization. Moreover, the relatively specific accumulation of photosensitizing PPIX within the tumor cells has gained interest in the PDT of malignant gliomas. Several experimental and clinical studies have then established ALA-PDT as a valuable adjuvant therapy in the management of malignant gliomas. However, the procedure still requires optimizations in the fields of tissue oxygenation status, photosensitizer concentration or scheme of laser light illumination. In this extensive review, we focused on the methods and results of ALA-PDT for treating malignant gliomas in experimental conditions. The biological mechanisms, the effects on tumor and normal brain tissue, and finally the critical issues to optimize the efficacy of ALA-PDT were discussed.

[1]  Tayyaba Hasan,et al.  Noninvasive measurement of aminolevulinic acid-induced protoporphyrin IX fluorescence allowing detection of murine glioma in vivo. , 2009, Journal of biomedical optics.

[2]  Seung Jo Kim,et al.  Fertility Preservation via Photodynamic Therapy in Young Patients With Early-Stage Uterine Endometrial Cancer: A Long-term Follow-up Study , 2013, International Journal of Gynecologic Cancer.

[3]  Sachio Suzuki,et al.  Histological examination of false positive tissue resection using 5-aminolevulinic acid-induced fluorescence guidance. , 2007, Neurologia medico-chirurgica.

[4]  M. Gilbert,et al.  Neoplastic and pharmacological influence on the permeability of an in vitro blood-brain barrier. , 1995, Journal of neurosurgery.

[5]  T J Dougherty,et al.  TIME and SEQUENCE DEPENDENT INFLUENCE OF IN VITRO PHOTODYNAMIC THERAPY (PDT) SURVIVAL BY HYPERTHERMIA , 1985, Photochemistry and photobiology.

[6]  Zheng Huang,et al.  Improvement of Tumor Response by Manipulation of Tumor Oxygenation During Photodynamic Therapy¶ , 2002, Photochemistry and photobiology.

[7]  Omar Alqawi,et al.  Molecular mechanisms associated with ALA-PDT of brain tumor cells , 2009, World Congress of the International Photodynamic Association.

[8]  P B Cerrito,et al.  The role of microvascular damage in photodynamic therapy: the effect of treatment on vessel constriction, permeability, and leukocyte adhesion. , 1992, Cancer research.

[9]  J. Hamada,et al.  Silencing of ferrochelatase enhances 5-aminolevulinic acid-based fluorescence and photodynamic therapy efficacy , 2011, British Journal of Cancer.

[10]  N. Al-Waili,et al.  Phototherapy and malignancy: possible enhancement by iron administration and hyperbaric oxygen. , 2006, Medical hypotheses.

[11]  Z. Malik,et al.  Nuclear distribution of porphobilinogen deaminase (PBGD) in glioma cells: a regulatory role in cancer transformation? , 2002, British Journal of Cancer.

[12]  Andreas Obermeier,et al.  Interstitial photodynamic therapy of nonresectable malignant glioma recurrences using 5‐aminolevulinic acid induced protoporphyrin IX , 2007, Lasers in surgery and medicine.

[13]  N. Khan,et al.  Repeated assessment of orthotopic glioma pO2 by multi-site EPR oximetry: A technique with the potential to guide therapeutic optimization by repeated measurements of oxygen , 2012, Journal of Neuroscience Methods.

[14]  F. Hetzel,et al.  Hyperoxygenation Enhances the Tumor Cell Killing of Photofrin-mediated Photodynamic Therapy¶ , 2003, Photochemistry and photobiology.

[15]  H. Steiger,et al.  Modulation of migratory activity and invasiveness of human glioma spheroids following 5-aminolevulinic acid-based photodynamic treatment. Laboratory investigation. , 2011, Journal of neurosurgery.

[16]  A. Obwegeser,et al.  Uptake and kinetics of 14C-labelled meta-tetrahydroxyphenylchlorin and 5-aminolaevulinic acid in the C6 rat glioma model. , 1998, British Journal of Cancer.

[17]  A. Kaye,et al.  Selective tumor kill of cerebral glioma by photodynamic therapy using a boronated porphyrin photosensitizer. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[18]  Mladen Korbelik,et al.  Photodynamic therapy-induced cell surface expression and release of heat shock proteins: relevance for tumor response. , 2005, Cancer research.

[19]  Henry Hirschberg,et al.  Effects of ALA‐mediated photodynamic therapy on the invasiveness of human glioma cells , 2006, Lasers in surgery and medicine.

[20]  A. Kaye,et al.  Modulation of light delivery in photodynamic therapy of brain tumours , 1999, Journal of Clinical Neuroscience.

[21]  Q. Peng,et al.  Induction of hypoxia-inducible factor-1alpha overexpression by cobalt chloride enhances cellular resistance to photodynamic therapy. , 2006, Cancer letters.

[22]  L. Lilge,et al.  Implicit and explicit dosimetry in photodynamic therapy: a New paradigm , 1997, Lasers in Medical Science.

[23]  Q. Peng,et al.  Protoporphyrin IX production and its photodynamic effects on glioma cells, neuroblastoma cells and normal cerebellar granule cells in vitro with 5-aminolevulinic acid and its hexylester. , 2003, Cancer letters.

[24]  Stefan Andersson-Engels,et al.  Photodynamic therapy: superficial and interstitial illumination. , 2010, Journal of biomedical optics.

[25]  Thomas Pongratz,et al.  ALA and malignant glioma: fluorescence-guided resection and photodynamic treatment. , 2007, Journal of environmental pathology, toxicology and oncology : official organ of the International Society for Environmental Toxicology and Cancer.

[26]  Henry Hirschberg,et al.  Repetitive photodynamic therapy of malignant brain tumors. , 2006, Journal of environmental pathology, toxicology and oncology : official organ of the International Society for Environmental Toxicology and Cancer.

[27]  M. Korbelik,et al.  Photodynamic therapy-generated vaccines: relevance of tumour cell death expression , 2007, British Journal of Cancer.

[28]  F. Floeth,et al.  Finding the anaplastic focus in diffuse gliomas: The value of Gd-DTPA enhanced MRI, FET-PET, and intraoperative, ALA-derived tissue fluorescence , 2011, Clinical Neurology and Neurosurgery.

[29]  D A Musser,et al.  The interaction of tumor localizing porphyrins with collagen and elastin. , 1982, Research communications in chemical pathology and pharmacology.

[30]  Bernhard Olzowy,et al.  Photoirradiation therapy of experimental malignant glioma with 5-aminolevulinic acid. , 2002, Journal of neurosurgery.

[31]  S. Gibson,et al.  Effects of various photoradiation regimens on the antitumor efficacy of photodynamic therapy for R3230AC mammary carcinomas. , 1990, Cancer research.

[32]  T. Dougherty,et al.  Potentiation of photodynamic therapy by heat: Effect of sequence and time interval between treatments in vivo , 1985, Lasers in surgery and medicine.

[33]  Jonathan Lerner,et al.  Intracranial glioblastoma models in preclinical neuro-oncology: neuropathological characterization and tumor progression , 2007, Journal of Neuro-Oncology.

[34]  Serge Mordon,et al.  Comparison of continuous and fractionated illumination during hexaminolaevulinate-photodynamic therapy. , 2008, Photodiagnosis and photodynamic therapy.

[35]  Henry Hirschberg,et al.  The effects of ultra low fluence rate single and repetitive photodynamic therapy on glioma spheroids , 2009, Lasers in surgery and medicine.

[36]  B. Wilson,et al.  Photo-Dynamic Therapy: Cavitary Photo-Illumination of Malignant Cerebral Tumours Using a Laser Coupled Inflatable Balloon , 1985, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[37]  S. K. Powers,et al.  Interstitial photoradiation injury of normal brain , 1992, Lasers in surgery and medicine.

[38]  Henry Hirschberg,et al.  Influence of light fluence rate on the effects of photodynamic therapy in an orthotopic rat glioma model. , 2006, Journal of neurosurgery.

[39]  M Chopp,et al.  The effect of light fluence rate in photodynamic therapy of normal rat brain. , 1992, Radiation research.

[40]  A. Curnow,et al.  Oxygen monitoring during 5-aminolaevulinic acid induced photodynamic therapy in normal rat colon. Comparison of continuous and fractionated light regimes. , 2000, Journal of photochemistry and photobiology. B, Biology.

[41]  F. Zanella,et al.  Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. , 2006, The Lancet. Oncology.

[42]  Herwig Kostron,et al.  Photodynamic diagnosis and therapy and the brain. , 2010, Methods in molecular biology.

[43]  J Moan,et al.  Antitumor effect of 5-aminolevulinic acid-mediated photodynamic therapy can be enhanced by the use of a low dose of photofrin in human tumor xenografts. , 2001, Cancer research.

[44]  W. Stummer,et al.  Transport of 5-aminolevulinic acid between blood and brain , 2003, Brain Research.

[45]  J. Baehring,et al.  Glioblastoma multiforme: overview of current treatment and future perspectives. , 2012, Hematology/oncology clinics of North America.

[46]  W. Star,et al.  In vivo fluorescence kinetics and photodynamic therapy using 5-aminolaevulinic acid-induced porphyrin: increased damage after multiple irradiations. , 1994, British Journal of Cancer.

[47]  M. Korbelik,et al.  Contribution of myeloid and lymphoid host cells to the curative outcome of mouse sarcoma treatment by photodynamic therapy. , 1999, Cancer letters.

[48]  Q. Peng,et al.  Correlation of subcellular and intratumoral photosensitizer localization with ultrastructural features after photodynamic therapy. , 1996, Ultrastructural pathology.

[49]  B. C. Wilson,et al.  The sensitivity of normal brain and intracranially implanted VX2 tumour to interstitial photodynamic therapy. , 1996, British Journal of Cancer.

[50]  T. Foster,et al.  ALA- and ALA-hexylester-induced protoporphyrin IX fluorescence and distribution in multicell tumour spheroids , 2001, British Journal of Cancer.

[51]  Rolf F. Barth,et al.  Rat brain tumor models in experimental neuro-oncology: the C6, 9L, T9, RG2, F98, BT4C, RT-2 and CNS-1 gliomas , 2009, Journal of Neuro-Oncology.

[52]  R. Mirimanoff,et al.  Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. , 2005, The New England journal of medicine.

[53]  Li Junliang,et al.  Antitumor efficacy of a photodynamic therapy-generated dendritic cell glioma vaccine , 2011, Medical oncology.

[54]  Mladen Korbelik,et al.  ENHANCED MACROPHAGE CYTOTOXICITY AGAINST TUMOR CELLS TREATED WITH PHOTODYNAMIC THERAPY , 1994, Photochemistry and photobiology.

[55]  J. Woodhams,et al.  Improved in vivo delivery of m-THPC via pegylated liposomes for use in photodynamic therapy. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[56]  Mladen Korbelik,et al.  Photodynamic therapy-generated vaccine for cancer therapy , 2006, Cancer Immunology, Immunotherapy.

[57]  A. Matsumura,et al.  The optimization of fluorescence imaging of brain tumor tissue differentiated from brain edema--in vivo kinetic study of 5-aminolevulinic acid and talaporfin sodium. , 2009, Photodiagnosis and photodynamic therapy.

[58]  Fan Zhang,et al.  Angiogenesis Induced by Photodynamic Therapy in Normal Rat Brain¶ , 2004, Photochemistry and photobiology.

[59]  Michael R Hamblin,et al.  Mechanisms in photodynamic therapy: Part three-Photosensitizer pharmacokinetics, biodistribution, tumor localization and modes of tumor destruction. , 2005, Photodiagnosis and photodynamic therapy.

[60]  T. Foster,et al.  Oxygen consumption and diffusion effects in photodynamic therapy. , 1991, Radiation research.

[61]  C. Rimington.  Porphyrin and haem biosynthesis and its control. , 2009, Acta medica Scandinavica. Supplementum.

[62]  Michael Sabel,et al.  Comparison of 18F-FET PET and 5-ALA fluorescence in cerebral gliomas , 2011, European Journal of Nuclear Medicine and Molecular Imaging.

[63]  P. Agostinis,et al.  NF-kappaB inhibition improves the sensitivity of human glioblastoma cells to 5-aminolevulinic acid-based photodynamic therapy. , 2011, Biochemical pharmacology.

[64]  Barbara W. Henderson,et al.  Choice of Oxygen-Conserving Treatment Regimen Determines the Inflammatory Response and Outcome of Photodynamic Therapy of Tumors , 2004, Cancer Research.

[65]  Hiroshi Iseki,et al.  Phase II clinical study on intraoperative photodynamic therapy with talaporfin sodium and semiconductor laser in patients with malignant brain tumors. , 2013, Journal of neurosurgery.

[66]  S. Eljamel.  Photodynamic applications in brain tumors: a comprehensive review of the literature. , 2010, Photodiagnosis and photodynamic therapy.

[67]  Michael R Hamblin,et al.  Mechanisms in photodynamic therapy: part two-cellular signaling, cell metabolism and modes of cell death. , 2005, Photodiagnosis and photodynamic therapy.

[68]  E. Alexander,et al.  Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial. , 1978, Journal of neurosurgery.

[69]  P. Kelly,et al.  Grading of astrocytomas: A simple and reproducible method , 1988, Cancer.

[70]  L. Deangelis,et al.  Randomized phase II trial of chemoradiotherapy followed by either dose-dense or metronomic temozolomide for newly diagnosed glioblastoma. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[71]  J Moan,et al.  5‐Aminolevulinic acid‐based photodynamic therapy , 1997, Cancer.

[72]  A. Curnow,et al.  The Hydroxypyridinone Iron Chelator CP94 Can Enhance PpIX‐induced PDT of Cultured Human Glioma Cells , 2010, Photochemistry and photobiology.

[73]  W. Kamphorst,et al.  Damage to Tumour and Brain by Interstitial Photodynamic Therapy in the 9L Rat Tumour Model Comparing Intravenous and Intratumoral Administration of the Photosensitiser , 1998, Acta Neurochirurgica.

[74]  Georg Hennig,et al.  Photobleaching-based method to individualize irradiation time during interstitial 5-aminolevulinic acid photodynamic therapy. , 2011, Photodiagnosis and photodynamic therapy.

[75]  E. Laskowski,et al.  THE RELATIONSHIP BETWEEN EDEMA, BLOOD‐BRAIN‐BARRIER AND TISSUE ELEMENTS IN A LOCAL BRAIN INJURY , 1958, Journal of neuropathology and experimental neurology.

[76]  A. J. MacRobert,et al.  Oral versus intravenous administration of 5-aminolaevulinic acid for photodynamic therapy. , 1993, British Journal of Cancer.

[77]  T. Strojnik,et al.  Experimental model and immunohistochemical analyses of U87 human glioblastoma cell xenografts in immunosuppressed rat brains. , 2006, Anticancer research.

[78]  M. Salcman,et al.  Hyperthermia for brain tumors: biophysical rationale. , 1981, Neurosurgery.

[79]  T. Wieman,et al.  THE EFFECTS OF THROMBOXANE INHIBITORS ON THE MICROVASCULAR AND TUMOR RESPONSE TO PHOTODYNAMIC THERAPY , 1993, Photochemistry and photobiology.

[80]  Lothar Lilge,et al.  Metronomic photodynamic therapy (mPDT): concepts and technical feasibility in brain tumor , 2003, SPIE BiOS.

[81]  S. K. Powers,et al.  Hyperthermia from interstitial laser irradiation in normal rat brain , 1987, Lasers in surgery and medicine.

[82]  N. Rainov.  A phase III clinical evaluation of herpes simplex virus type 1 thymidine kinase and ganciclovir gene therapy as an adjuvant to surgical resection and radiation in adults with previously untreated glioblastoma multiforme. , 2000, Human gene therapy.

[83]  D. Bellnier.  Potentiation of photodynamic therapy in mice with recombinant human tumor necrosis factors-α , 1991 .

[84]  Henry Hirschberg,et al.  Photodynamic therapy of newly implanted glioma cells in the rat brain , 2006, Lasers in surgery and medicine.

[85]  B. Henderson,et al.  Reduction of tumour oxygenation during and after photodynamic therapy in vivo: effects of fluence rate. , 1998, British Journal of Cancer.

[86]  Hirofumi Fujita,et al.  The inhibition of ferrochelatase enhances 5-aminolevulinic acid-based photodynamic action for prostate cancer. , 2013, Photodiagnosis and photodynamic therapy.

[87]  A. Curnow,et al.  Comparing and combining light dose fractionation and iron chelation to enhance experimental photodynamic therapy with aminolevulinic acid , 2006, Lasers in surgery and medicine.

[88]  Henry Hirschberg,et al.  Disruption of the blood–brain barrier following ALA‐mediated photodynamic therapy , 2008, Lasers in surgery and medicine.

[89]  M. Korbelik,et al.  Photodynamic therapy-mediated immune response against subcutaneous mouse tumors. , 1999, Cancer research.

[90]  P. Agostinis,et al.  5-ALA-PDT induces RIP3-dependent necrosis in glioblastoma , 2011, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.

[91]  W. Stummer,et al.  In vitro and in vivo porphyrin accumulation by C6 glioma cells after exposure to 5-aminolevulinic acid. , 1998, Journal of photochemistry and photobiology. B, Biology.

[92]  M. Hefti,et al.  Phenytoin reduces 5-aminolevulinic acid-induced protoporphyrin IX accumulation in malignant glioma cells , 2012, Journal of Neuro-Oncology.

[93]  Johan Moan,et al.  On the selectivity of 5-aminolevulinic acid-induced protoporphyrin IX formation. , 2004, Current medicinal chemistry. Anti-cancer agents.

[94]  T. Cloughesy,et al.  mTOR signaling in glioblastoma: lessons learned from bench to bedside , 2010, Neuro-oncology.

[95]  S. Stylli,et al.  Selective tumor uptake of a boronated porphyrin in an animal model of cerebral glioma. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[96]  M. Chopp,et al.  Combination Therapy with Antiangiogenic Treatment and Photodynamic Therapy for the Nude Mouse Bearing U87 Glioblastoma , 2007, Photochemistry and photobiology.

[97]  Lenka Dzurová,et al.  Cell death response of U87 glioma cells on hypericin photoactivation is mediated by dynamics of hypericin subcellular distribution and its aggregation in cellular organelles , 2012, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.

[98]  Q. Peng,et al.  Localization of fluorescent photofrin ii and aluminum phthalocyanine tetrasulfonate in transplanted human malignant tumor LOX and normal tissues of nude mice using highly light‐sensitive video intensification microscopy , 1990, International journal of cancer.

[99]  S. Stylli,et al.  Photodynamic therapy of cerebral glioma – A review Part I – A biological basis , 2006, Journal of Clinical Neuroscience.

[100]  Bruce J. Tromberg,et al.  Repetitive 5-aminolevulinic acid-mediated photodynamic therapy on human glioma spheroids , 2003, Journal of Neuro-Oncology.

[101]  W. Rachinger,et al.  Oedema formation in experimental photo-irradiation therapy of brain tumours using 5-ALA , 2004, Acta Neurochirurgica.

[102]  Walter Stummer,et al.  Kinetics of Photofrin II in perifocal brain edema. , 1993, Neurosurgery.

[103]  H. Hirschberg,et al.  Cerebral edema following photodynamic therapy using endogenous and exogenous photosensitizers in normal brain , 2011, Lasers in surgery and medicine.

[104]  T. Foster,et al.  Effectiveness of delta-aminolevulinic acid-induced protoporphyrin as a photosensitizer for photodynamic therapy in vivo. , 1995, Cancer research.

[105]  Michael R Hamblin,et al.  Mechanisms in photodynamic therapy: part one-photosensitizers, photochemistry and cellular localization. , 2004, Photodiagnosis and photodynamic therapy.

[106]  M. Chopp,et al.  Low-dose photodynamic therapy increases endothelial cell proliferation and VEGF expression in nude mice brain , 2005, Lasers in Medical Science.

[107]  T. Hasan,et al.  In vivo fluence rate and fractionation effects on tumor response and photobleaching: photodynamic therapy with two photosensitizers in an orthotopic rat tumor model. , 1999, Cancer research.

[108]  S. Iinuma,et al.  A mechanistic study of cellular photodestruction with 5-aminolaevulinic acid-induced porphyrin. , 1994, British Journal of Cancer.

[109]  Ronald Sroka,et al.  Acute morphological sequelae of photodynamic therapy with 5-aminolevulinic acid in the C6 spheroid model , 2007, Journal of Neuro-Oncology.

[110]  S. Mordon,et al.  Continuous or fractionated photodynamic therapy? Comparison of three PDT schemes for ovarian peritoneal micrometastasis treatment in a rat model. , 2010, Photodiagnosis and photodynamic therapy.

[111]  M. Sam Eljamel,et al.  ALA and Photofrin® Fluorescence-guided resection and repetitive PDT in glioblastoma multiforme: a single centre Phase III randomised controlled trial , 2008, Lasers in Medical Science.

[112]  Alison Curnow,et al.  Light Dose Fractionation to Enhance Photodynamic Therapy Using 5‐Aminolevulinic Acid in the Normal Rat Colon , 1999, Photochemistry and photobiology.

[113]  M. Chopp,et al.  Sensitization of cerebral tissue in nude mice with photodynamic therapy induces ADAM17/TACE and promotes glioma cell invasion. , 2008, Cancer letters.

[114]  Jochen Herms,et al.  5‐Aminolevulinic Acid‐induced Protoporphyrin IX Levels in Tissue of Human Malignant Brain Tumors , 2010, Photochemistry and photobiology.

[115]  J C Kennedy,et al.  NON‐INVASIVE TECHNIQUE FOR OBTAINING FLUORESCENCE EXCITATION AND EMISSION SPECTRA IN VIVO , 1986, Photochemistry and photobiology.

[116]  W. Star,et al.  Effect of photodynamic therapy on the endothelium-dependent relaxation of isolated rat aortas. , 1993, Cancer research.

[117]  A H Kaye,et al.  Phase I and pharmacokinetic study of photodynamic therapy for high-grade gliomas using a novel boronated porphyrin. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[118]  D P Byar,et al.  Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery. , 1980, The New England journal of medicine.

[119]  Andrew H. Kaye,et al.  Photodynamic therapy of high grade glioma – long term survival , 2005, Journal of Clinical Neuroscience.

[120]  G von Campe,et al.  5-aminolevulinic acid induced protoporphyrin IX fluorescence in high-grade glioma surgery: a one-year experience at a single institutuion. , 2008, Swiss medical weekly.

[121]  L. Lilge,et al.  Apoptosis induced in vivo by photodynamic therapy in normal brain and intracranial tumour tissue , 2000, British Journal of Cancer.

[122]  A. E. Saarnak,et al.  5-Aminolevulinic Acid Induced Endogenous Porphyrin Fluorescence in 9L and C6 Brain Tumours and in the Normal Rat Brain , 1998, Acta Neurochirurgica.

[123]  Bruce J. Tromberg,et al.  ALA- and ALA-ester-mediated Photodynamic Therapy of Human Glioma Spheroids , 2002, Journal of Neuro-Oncology.

[124]  N. Pimstone,et al.  The interaction of tumour‐localizing porphyrins with collagen, elastin, gelatin, fibrin and fibrinogen , 1985, Cell biochemistry and function.

[125]  Mladen Korbelik,et al.  PDT‐associated host response and its role in the therapy outcome , 2006, Lasers in surgery and medicine.

[126]  T. Kubota,et al.  A phase I/II clinical trial investigating the adverse and therapeutic effects of a postoperative autologous dendritic cell tumor vaccine in patients with malignant glioma , 2011, Journal of Clinical Neuroscience.

[127]  M. V. van Gemert,et al.  Fluorescence localization in tumour and normal brain after intratumoral injection of haematoporphyrin derivative into rat brain tumour. , 1995, Journal of photochemistry and photobiology. B, Biology.

[128]  L. Lilge,et al.  Fluorescence image-guided brain tumour resection with adjuvant metronomic photodynamic therapy: pre-clinical model and technology development , 2005, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.

[129]  Bruce J. Tromberg,et al.  Enhanced cytotoxic effects of 5-aminolevulinic acid-mediated photodynamic therapy by concurrent hyperthermia in glioma spheroids , 2004, Journal of Neuro-Oncology.

[130]  Lothar Lilge,et al.  Metronomic Photodynamic Therapy as a New Paradigm for Photodynamic Therapy: Rationale and Preclinical Evaluation of Technical Feasibility for Treating Malignant Brain Tumors¶ , 2004, Photochemistry and photobiology.

[131]  D. Kessel,et al.  Side effects and photosensitization of human tissues after aminolevulinic acid. , 1997, The Journal of surgical research.

[132]  B W Henderson,et al.  Relationship of tumor hypoxia and response to photodynamic treatment in an experimental mouse tumor. , 1987, Cancer research.

[133]  H. C. de Vijlder,et al.  Light fractionation significantly improves the response of superficial basal cell carcinoma to aminolaevulinic acid photodynamic therapy: five-year follow-up of a randomized, prospective trial. , 2012, Acta dermato-venereologica.